Genmab
GMAB
#1352
Rank
HK$101.76 B
Marketcap
HK$159.55
Share price
0.24%
Change (1 day)
-36.92%
Change (1 year)

Earnings for Genmab (GMAB)

Earnings in 2024 (TTM): HK$8.40 Billion

According to Genmab's latest financial reports the company's current earnings are HK$2.74 Billion. In 2023 the company made an earning of HK$6.27 Billion a decrease over its 2022 earnings that were of HK$7.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Genmab from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$8.40 B33.94%
2023 HK$6.27 B-16.82%
2022 HK$7.54 B55.87%
2021 HK$4.83 B-31.09%
2020 HK$7.02 B111.51%
2019 HK$3.32 B69.44%
2018 HK$1.95 B49.63%
2017 HK$1.30 B3.27%
2016 HK$1.26 B46.33%
2015 HK$0.86 B117.13%
2014 HK$0.39 B329.17%
2013 HK$92.99 M-159.26%
2012 -HK$0.16 Billion-48.96%
2011 -HK$0.31 Billion90.86%
2010 -HK$0.17 Billion-67.46%
2009 -HK$0.5 Billion